China Risun Group Limited reported audited results for the year ended 31 December 2025, showing a strong rebound in bottom-line performance despite revenue pressure.

Key operating metrics • Coke output climbed 7.8% year-on-year (YoY) to 17.80 million tons, while refined-chemicals processing rose 5.0% to 5.20 million tons. • High-purity hydrogen production increased 25.7% YoY to 25.30 million Nm³.

Financial highlights • Revenue fell 17.4% YoY to RMB39.29 billion, reflecting lower product prices across coke and chemicals. • Gross profit slipped 12.2% to RMB3.06 billion, yet the gross margin improved to 7.8% (2024: 7.3%) on tighter cost control and depreciation savings from extended asset lives. • Profit from operations rose 7.7% to RMB1.52 billion; net finance costs edged down 1.4% to RMB1.39 billion. • Profit before tax advanced 67.5% to RMB183.24 million; net profit attributable to shareholders surged 187.9% to RMB58.01 million, lifting basic EPS to RMB0.013 (2024: RMB0.005). • EBITDA margin widened to 9.2% (2024: 8.1%).

Segment performance • Coke & coking chemicals revenue dropped 23.4% to RMB13.52 billion, but segment gross margin expanded to 12.4% (2024: 8.6%) on lower coal costs. • Refined chemicals revenue declined 14.1% to RMB17.80 billion; gross margin contracted to 4.5% amid narrower spreads in caprolactam and styrene. • Trading revenue grew 25.6% to RMB5.96 billion, supported by a 1.55 million-ton increase in volumes. • Operation-management revenue fell 57.3% to RMB1.80 billion following the expiry of three service contracts. • Other income (mainly rental and property sales) rose 4.5% to RMB214.82 million, with gross margin sharply higher at 50.4%.

Cash flow and balance sheet • Operating cash inflow more than doubled to RMB3.46 billion, aided by tighter working-capital management. • Net cash used in investing activities totalled RMB3.41 billion, largely for capacity expansion. • Total interest-bearing debt stood at RMB34.43 billion (+13.2% YoY); gearing increased to 2.3 times, while the debt-to-asset ratio reached 75.6%. • The Group held RMB1.58 billion in cash and cash equivalents at period end, down from RMB2.09 billion a year earlier. Net current liabilities widened to RMB14.21 billion. • Unutilised banking facilities amounted to RMB8.04 billion; management expects around 60% of maturing loans to be renewed.

Capital expenditure and strategy • Additions to non-current assets reached RMB2.53 billion, focused on new coke capacity in Pingxiang, hydrogen projects and high-value chemicals such as amino alcohols. • A change in asset useful-life estimates reduced 2025 depreciation by roughly RMB195 million, benefiting operating profit. • Management highlighted ongoing expansion, R&D for higher-margin chemicals, and development of liquid-hydrogen capabilities to underpin its seventh Five-Year Plan (2026-2030).

Dividend The Board proposes a final dividend of RMB0.19 fen (RMB0.0019) per share, totalling approximately RMB8.13 million, subject to shareholder approval at the May 2026 AGM.

Events after year-end No material subsequent events were reported up to 27 March 2026.

Outlook The company will continue to pursue capacity expansion, deepen cost-efficiency measures and develop value-added chemical and hydrogen businesses while managing leverage and liquidity.